date:Feb 11, 2014
native medicine continued to use it, so we felt further study was in order, said the study's senior author, Qi Chen, assistant professor in KU Medical Center's Department of Pharmacology, Toxicology and Therapeutics and the Department of Integrative Medicine. What we've discovered is that, because of its pharmacokinetic differences, intravenous vitamin C, as opposed to oral vitamin C, kills some cancer cells without harming normal tissues.
The researchers' clinical trial involved 27 patients wi